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ABSTRACT 
 
Objectives: Comparing the clinical & microbiological profiles of patients with tuberculosis and nontuberculosis 
empyema. Materials and Methods: A prospective study of adult cases of nonsurgical thoracic empyema admitted 
in a tertiary care hospital in warangal :telangana state  was performed over a period of 18 months. A comparative 
analysis of clinical characteristics, treatment modalities, and outcomes of patients with tuberculosis and 
nontuberculosis empyema was carried out. Results: Fifty  cases of empyema were seen during the study period, of 
which 24 (,48%) were of nontuberculosis etiology while tuberculosis constituted 26(, 52%) cases. Among the 
nontuberculosis empyema patients, pseudomonas 8(   16%) was the most frequent pathogen isolated. Tuberculosis 
empyema was more frequent in younger population compared to nontuberculosis empyema (mean age of 30.6 years 
vs. 48.5 years). Duration of illness and mean duration of chest tube drainage were longer (40.7 vs. 20.2 days) in 
patients with tuberculosis empyema. Also the presence of parenchymal lesions and bronchopleural fistula often 
requiring surgical drainage procedures was more in tuberculosis empyema patients. Conclusion: Tuberculosis 
empyema remains a common cause of empyema thoracis in a country like India. Tuberculosis empyema differs from 
nontuberculosis empyema in the age profile, clinical presentation, management issues, and has a significantly poorer 
outcome 
 
Keywords: Empyema, Parapneumonic effusions, Tuberculosis, Pneumothorax, Pyopneumo thorax, Decortication, 
Intrapleural
  
Introduction 
 
Ever since the days of Hippocrates Empyema thoracis 
has been known as pus in the Pleural cavity. Empyema 
is the most common exudative type of pleural effusion. 
Empyema is never a primary disease, often it is 
difficult to arrive at primary focus of Infection, 
through pleural cavity is the root of pus, the respiratory 
and cardiovascular System are severely affected. For 
centuries Empyema thoracis has been recognized as a 
serious problem. The development of antibiotic 
resistance has also added to the gravity of the 
condition. The situation has been made worse by the 
poor economic state and bad hygienic condition in our  
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country. In developed countries non mycobacterial 
pulmonary infections and surgical procedures 
constitute the majority of thoracic empyema cases [1], 
Staphylococcus and pneumococci are the commonest 
organisms isolated from the pleural pus. Rest of the 
isolates includes gram-negative organisms and 
anaerobes. Gram-negative organisms are frequently 
isolated, presumably, because of high incidence of 
resistance of these organisms to commonly used 
antibiotics in the early phase of empyema. Streptococci 
were rarely, if ever seen as a cause of empyema. More 
than one isolate was found in many patients and it is 
well documented. This justifies the use of combination 
of antibiotics as an empirical form of treatment. Where 
as in the developing world tuberculosis accounts for a 
sizeable number [2] Clinical outcomes of tuberculosis 
empyema are generally believed to be worse compared 
to those of non-tuberculosis empyema because of 
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protracted illness, presence of concomitant 
fibrocavitary lung lesions, high bacillary load, 
development of bronchopleural fistulae (BPF), and 
requirement for complicated thoracic surgeries in the 
face of compromised lung function. [3]With this 
scenario in mind, we decided to conduct this study in 
our Tertiary care hospital setup to define the clinical 
course, bacteriological profile, radiological features, 
various modalities of treatment and their outcome in 
50 cases of empyema thoracis. This would guide us to 
use appropriate antibiotics and management strategies. 
[4] 
 
Aims and objectives 
 
1. To know the common etiological factors 
contributing to Empyema  
2. To know the predisposing and precipitating 
factors  
3. To know the age, sex, geographical 
distribution.  
4. To know the relation between the early 
intervention and prognosis.  
 
Materials and methods 
 
Study Design: This study was a prospective analysis 
of all adult cases of nonsurgical thoracic empyema 
admitted in the department of respiratory medicine of 
GOVT CD & TB Hospital Hanamakonda, Telangana 
State over a period of 2 years between 2013 to 2015. 
Patient Selection: 
Case Definition: 
Thoracic empyema was defined as pleural effusion that 
fulfilled at least one of the following criteria: 
(1) The presence of frank pus on pleural 
aspiration;  
(2) Presence of organism on pleural fluid culture;  
(3) Positive pleural fluid Gram stain.  
Tuberculosis empyema was defined as cases of 
thoracic empyema with one of the following: 
(1) Pleural fluid smear positive for acid fast 
bacilli (AFB);  
(2) Sputum positive for AFB and having 
radiological lesions consistent with active 
parenchymal tuberculosis on chest x-ray/CT 
scan of the thorax (nodular consolidation with 
or without cavity in apex, tree in bud 
appearance).  
(3) Probable tuberculous empyema was defined 
as empyema in patients who had radiological 
evidence of active pulmonary tuberculosis on 
chest x-ray/CT scan of the thorax or were 
sputum positive for AFB. 
Sample Size: 50 adult patients with the age group 
more than 18 years who were admitted with the 
diagnosis of empyema were included in the study. 
Inclusion Criteria: 
1) All Adult Patients 18years & above.  
2) Clinical features compatible with Empyema.  
3) Chest X-ray appearance of Empyema.  
4) CT scan of chest with contrast.  
5) Loculated Empyema & Non Loculated 
Empyema  
6) Written consent.  
Exclusion Criteria: 
1) Empyema secondary to penetrating or blunt 
chest trauma  
2) Very Sick Patients.  
3) Death in the process of evaluation.  
4) Contra Indications to thoracocentesis like 
uncooperative patients.  
5) Withdrawal of consent at any time during 
study period. [5-9] 
Study Protocol: During this study a simplified clinical 
approach is adopted in patients who were admitted in 
the inpatient department with symptoms and signs 
suggestive of Empyema Thoracis. Detailed 
demographic and clinical parameters including age, 
sex, symptom duration (fever, weight loss, cough, 
sputum, hemoptysis, shortness of breath, chest pain) 
were evaluated in all patients fulfilling the case 
definition. Presence of anycomorbidities like diabetes 
mellitus, HIV infection, seizure disorder, liver abscess, 
rheumatoid arthritis, and malignancy was documented. 
Complete physical examination was done. Routine 
investigations which include CBP, TLC, DLC, ESR, 
RBS, specific investigations like sputum for AFB, 
Mantoux test was done. Chest radiographs were 
obtained in all patients at the admission. . In all 
clinically suspected cases diagnostic thoracocentesis 
was performed under local anesthesia with 2% 
xylocaine using sterile disposable syringe (needle size- 
18 G), which was introduced through 5th intercostal 
space in mid axillary line or area of maximal dullness, 
appearance of pus clinches the diagnosis. About 100 
ml of pus was drawn in each case and sent for 
cytology, TLC DLC ADA LDH,glucose, protein,sugar 
microbiology for gram stain, aerobic culture and 
sensitivity, AFB stain.[10-12]Those in severe 
distressunderwent immediate ICD. . Intercostal 
drainage procedure was done with all aseptic 
precautions with prior consent taken and inserted in 5th 
intercostal space in mid axillary line, outer end of the 
tube was connected to an underwater seal kept in 
sterile condition.Initially intravenous antibiotics like 
Amoxicillin-clavulanic acid started in the dose of 2400 
mg/day in two divided doses and Amikacin in the dose 
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of 1000 mg per day in two divided doses, 
Metronidazole 1500mg per day in three divided doses 
given. Appropriate antibiotics were added according to 
culture sensitivity reports. Chest x ray was 
immediately taken after ICD insertion to confirm the 
exact position of the tube, as well as to document lung 
expansion and residual collection subsequently. Daily 
bedside examination was done to check for vital 
signs,air entry and the patency of the ICD tube. 
Whenever blockage was suspected, intercostal tube 
was readjusted. For those with persistent symptoms 
and no signs of improvement, ultrasound or CT was 
done to look for any loculations following tube 
thoracostomy. All patients were advised on good 
nutritional intake. Chest physiotherapy was started at 
the earliest. All of them were encouraged to blow 
balloons or use incentive spirometry for good lung 
expansion. ICD was removed when the drainage was 
less than 50 ml/day with radiological and clinical 
improvement. Appropriate antibiotics were given for a 
minimum of 4-6 weeks depending on the clinical 
condition of the patient and organism isolated. Patients 
were discharged after confirming good lung expansion 
and absence of fever. All the patients with persistent 
clinical symptoms, incomplete lung expansion on ICD 
and antibiotics, persistent BPF,multiple loculations and 
thick pleural peel seen on ultrasonography / CT at 
admission or developed during the course of hospital 
stay were subjected to surgical line of management. 
All the patients were advised for follow up at 1 and 3 
months. Those who came for follow up were assessed 
for lung expansion and deformities of the chest wall by 
clinical examination and chest x-ray if necessary. 
Ethical clearance was obtained for this study. 
Statistical analysis: Statistical analyses were 
performed using SPSS version 10.0 (SPSS inc., 
Chicago, IL) software for MS-Windows. Descriptive 
frequencies were expressed using mean. P value was 
calculated using Fisher’s test of significance.  
Independent sample t test for continuous variables, and 
P value <0.05 was considered to be significant. Mean, 
standard deviation, were also calculated where 
relevant.[13-15] 
 
                            
 
    Fig 1: Plain radiograph chest showing right side intercostal 
drainage tube in situ 
 
Fig 2: Plain radiograph chest showing Hydropneumothorax on 
the left side 
 
 
Fig 3:Axial contrast – enhanced CT scan of the chest on the left 
showing thickening, increased contrast uptake of the parietal 
pleura with loculated fluid and air in the pleural space 
 
Fig 4:Microscopic image of AFB 
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Observations and results 
 
Total Cases 50   
 
Table 1: Age Distribution of Empyema 
 
Age Number of cases Percentage 
18-20 2 4% 
21-30 10 20% 
31-40 18 36% 
41-50 15 30% 
>50 5 10% 
Total: 50 100% 
 
 
In this study majority of cases were in the age group of 
31-40 years (4thdecade) Constituting of 18 patients and 
36% of the total. This was followed by the 41-50 years 
Group where there were 15 patients constituting 30% 
of the total. Put together 31-50years age interval has 
66% of the total patients. Youngest patient was 18yr 
old and the oldest was 75 years old.  
 
Gender Distribution  
Table 2: Gender Distribution 
 
Sex Number of cases Percentage 
Male 46 92% 
Female 4 8% 
Total: 50 100% 
 
In this study 92% of patients were male constituting the majority. 
 
Symptoms 
 
Table 3: Showing Symptom Analysis 
 
Major symptom Number of cases Percentage 
Cough 46 92% 
Fever 44 88% 
Sob 42 84% 
Chest Pain 30 60% 
Weight Loss 22 44% 
 
 
In the present study the commonest presentation of empyema thoracic was Cough (92%), followed by fever (88%), 
SOB (84%), chest pain (60%) and weight loss (44%).  
Duration of Symptoms at the Time of Presentation 
 
Table 4: Duration of Symptoms 
 
Duration of Symptoms Number of Cases Percentage 
<7 Days 1 2% 
7 to 14 Days 14 28% 
15 to 30 Days 05 10% 
1 Month 30 60% 
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Mean duration of presentation after the onset of 
symptoms was 24 days. 30(60%) of the cases 
presented 1 month after the onset of symptoms. 14 
(28%) of the cases presented after 1 week. 
Associated Conditions: Alcohol l& tuberculosis were 
the major associated conditions seen in 44% of patients 
each ,next most associated condition was smoking 
(38%), many were current smokers 4(8%) were ex-
smokers.HIV, malignancy (NSCLC) seen in one 
patient each. 
 
Table 5: Showing Associated Conditions 
 
Associated condition Number of cases Percentage 
Smoking 19 38 
DM 4 8 
Alcohol 22 44 
Tuberculosis 22 44 
HIV 1 2 
Malignancy 1 2 
 
Diagnosis at Admission 
Table 6: Diagnosis at Admission 
 
Diagnosis Number of patients Percentage 
Right sided empyema 38 76 
Left sided empyema 11 22 
Bilateral empyema 1 02 
 
Majority patients were having right side empyema 76%, remaining 22 % had left side empyema .only single patient 
had bilateral empyema. 
Etiology 
 
Table 7: Showing the Etiology of Empyema Thoracis 
 
Etiology Number of cases Percentage 
Tubercular 26 52% 
CAP 19 38% 
Lung Abcess 03 06% 
Post Thoracocentecis (Iatrogenic) 02 04% 
 
The most common etiology was tuberculosis in 26(52%) patients, followed by lung community acquired pneumonia 
in 19 (38%) and lung abscess in 3(6%). There was 2 case of empyema thoracic caused by Thoracentesis. 
Microbiology: 
 
Table 8: Showing the Microbiological Organism Cultured in the Pleural Aspirate 
Microbiological Organism Number(N=50) Percentage 
Gram +ve 05 10 
 Staph aureus 04 8 
 Streptpneumoniae 01 2 
Gram -ve 12 24 
 Pseudomonas 08 16 
 Ecoli 02 4 
 Klebsiella 01 2 
 Multiple Organisms 01 2 
AFB Stain positive 03 6 
Sterile 30 60 
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Many cases were sterile 30(60%). Bacteriological 
isolation was seen in 20(40%)cases. Majority were 
12(24%) showing gram negative organisms. Among 
the gram negative Organisms, pseudomonas 8(16%) 
were the commonest organism isolated. Followed by E 
coli 2(4%), Klebsiella 1 (2%).Among the gram 
positive organisms, staphylococci 4 (8%) and 
pneumococci 1(2%) were the commonest organisms 
isolated .one case was showing polymicrobial variety 
Klebsiella,proteus were seen.AFB stain positive was 
seen in 3 cases.[16-18] 
 
Radiological Pattern of Empyema 
                                                                Table 9:Radiological Pattern of Empyema 
 
Radiological Pattern Number of patients Percentage 
CXR:   
Pleural Effusion 38 76% 
Hydro pneumothorax 12 24% 
USG/ CT:   
Multi loculated (ML) 08 16% 
Non Loculated (NL) 28 56% 
ML + hydropneumothorax 06 12% 
Not done 08 16% 
 
38 (76%) had pleural effusion on X-ray and 12(24%) 
cases had Hydro pneumothorax. 8(16%) of the cases 
had loculated empyema as most of them were in 
chronic presentation group (fibrinopurulent stage), 28 
(56%) had non-loculated and 6 (12%) had 
hydrpneumothorax with loculations. 
 
Diagnosis of Tubercular Empyema 
 
Table 10:Diagnostic Criteria of Tubercular Empyema 
 
Diagnostic Criteria Number & Percentage 
Sputum positive 18 (69.2%) 
Pleural fluid AFB Stain positive 03(11.5%) 
Past H/o PTB 18(69.2%) 
Mantoux Test 24(92.3%) 
CT Showing active infiltrates 10(38.5%) 
 
Of the 26 patients diagnosed as having tubercular 
empyema, the diagnosis was established 
bacteriologically, i.e., based on the presence of AFB in 
sputum and/or empyema fluid in 18 patients (70%). In 
the remaining 8 cases (30%), this diagnosis was based 
on clinical grounds, i.e., previous h/o pulmonary 
tuberculosis, mantoux positivity, radiological 
appearances consistent with active tuberculosis and 
response to anti-tuberculous treatment. 
 
Comparison of Tuberculosis& Non-Tuberculosis 
Cases of Empyema Thoracis: The majority (21 cases, 
80.7%) of tuberculosis empyema cases belonged to a 
relatively younger age group (18–40 years), whereas 
66.7% (16 cases) of non tuberculosis empyema 
patients were above 45 years of age. Mean age in the 
tuberculosis empyema group was 30.6 years (range: 
14–65 years) compared to mean age of 48.5 years 
(range: 30–72 years) in non tuberculosis group. 
Twenty-four cases (92%) of tuberculosis empyema had 
illness of more than cases (25%) of non tuberculosis 
empyema had duration of more than 1 month and 
mean duration of illness was significantly higher in 
tuberculosis group (mean 78.6 days) compared to non 
tuberculosis group (mean 21.4 days).  
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Table 11: Clinical Comparison of Tuberculosis &Non-Tuberculosis Cases 
 
 Tuberculosis SD Non- Tuberculosis SD P-Value 
Age (mean) 30.6 yrs 8.45 48.5 yrs 15.4 0.0001 
Duration of illness (>1 
Month)-Mean 
24 (92%)- 
70.2 days 
11.26 6 (25%)- 
20 days 
4.8 0.0001 
Cough 25 (96%)  21 (87%)  0.4897 
Fever 20 (77 %)  24 (100%)  0.023 
SOB 18 (70%)  24 (100%)  0.49 
Hemoptysis 08 (30.7 %)  1 (4%)  0.0244 
BMI <18.5 14 (53.8%)  5 (20.8%)  0.0215 
Past H/o PTB 18 (69.2%)  04 (16%)  0.0001 
H/o Contact with PTB 21 (80.7%)  07 (29%)  0.0005 
TLC (Blood) 10,200.4cumm 1153.7 14,841.2cumm 1327.6 <0.0001 
ESR 1st Hour 48 6.8 51 11.2 0.2538 
Mantoux 24 (92.3%)  7 (29%)  0.0001 
 
 
There was not much difference in routine laboratory 
markers between the two groups, mean TLC was 
10200.4/cumm, and mean ESR was 48 mm at the end 
of first hour in the tuberculosis group, corresponding 
values in the non tuberculosis group were 
14,841.2/cumm and 51 mm, respectively. All non 
tuberculosis empyema patients had fever, which was 
also present in 77% of tuberculosis empyema 
patients.Hemoptysis was more common in tuberculosis 
compared to non tuberculosis empyema (8 cases, 
30.7% vs. 1 case, 4%).Many tubercular patients 
14(53.8%) were had BMI<18.5, only 5 cases (20.8%) 
of non-tubercular patients were belonged to this group. 
past h/o PTB was significant in tubercular cases 69.2% 
(18 cases) many were defaulters 61.5% (16 cases) 
were CAT1 defaulters, 2 cases were CAT2 defaulters. 
Only 4(16%) were had h/o PTB in non-tubercular 
cases. 
 
Table12:Comparison of Associated Conditions 
 
Co Morbidity Tuberculous Non-Tuberculous 
DM 1(3.8%) 3(12.5%) 
HIV 1(3.8%) 0 
COPD 7 (26.9%) 12 (50%) 
Alcoholism 8 (30.8%) 14 (58%) 
Malignancy 0 1(4%) 
 
Alcoholism was the commonest co morbid condition seen 
in 22 (44%) of total cases. In that 8 cases (30.8%) were 
tubercular, 14 (58%) cases were non tubercular. COPD 
was seen in50% (12 cases) of non-tubercular, 27%(7 
cases)of tubercular empyema. Other co morbid conditions 
were DM, HIV, NSSLC. 
 
             Table13: Comparison of Pleural Fluid Analysis in Tuberculous, Non-Tuberculous Cases of Empyema 
 
Pleural Fluid 
Analysis 
Tuberculous (Mean) SD Non-Tuberculous (Mean) SD P-Value 
Protein gm/dl 3.4 0.8 5.2 1.2 <0.0001 
Sugar  mg/dl 52.2 4.6 40.4 6.7 <0.0001 
TLC/mm3 1026.6 204.8 1500.2 236.8 <0.0001 
ADA 58.6 14.6 276 32.7 <0.001 
LDH 1536.7 123.8 6030.2 342.4 <0.001 
 
 
Tubercular empyema patients had glucose mean value 52.2 mg/dl, protein 3.4mg/dl while glucose mean was 
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40.4 mg/dl in non-tubercular cases, protein mean was 
3.4gm/dl.TLC average was 1026.6,1500.2 in tubercular 
and non-tubercular cases.  Both were PMN predominant. 
ADA mean was 58.6, LDH mean1536.7 in tubercular, 
276, 6030.2 respectively in non-tubercular. 
Table 14: Comparison of Treatment &Outcome 
 
Treatment & Outcome Tuberculous SD Non-Tuberculous SD P-Value 
Duration of Hospitalization 48.4 days 12.4 20.2 days 9.8 0.0001 
Duration  of ICD Tube 40.7 days 7.3 18. 6 days 5.1 0.001 
BPF 17 (65.3%)  5 (20.8%)  0.002 
Resolution 14(53.8%)  23 (95.8%)  0.0009 
 
The drainage modalities in non-tuberculous empyema 
were intercostal tube drainage in 18 cases (75%), and 
serial aspirations in 8 cases (33.3%). ICD was done in all 
tubercular empyema cases. The treatment default cases 
were put on category II DOTS. Seventeen patients 
(65.4%) in the tuberculous empyema group required 
ICTD for more than 1 month compared to only 6(25%) in 
the non-tuberculous group; mean duration of intercostal 
tube drainage was also higher in the tubercular group 
(40.7 days) as against the non-tubercular group (20.2 
days). BPF was seen in 17 (65.3) cases of tubercular, 
5(20.8%) of non-tubercular empyema. Good lung 
expansion with minimal pleural thickening seen in 23 
cases (95.8%) of non-tubercular cases. But only 14 
(53.3%) cases of tubercular empyema had resolution. 
Twelve patients (46.6%) with tuberculous empyema 
required surgery despite ATT and ICTD, whereas only 
one (4%) in the non-tuberculous group needed surgery 
 
Discussion 
 
Age Incidence: The high incidence of empyema in the 
productive age group of 21-40 years in this study (56%) is 
consistent with the findings in the earlier studies by 
Acharya et al, S Kundu, Behra and Tandon [19-21](58%). 
This may be due to the common occurrence of pulmonary 
tuberculosis particularly in the developing countries with 
a high prevalence of tuberculosis. Two other studies show 
the incidence of empyema to be higher after the age of 40. 
This may be attributed to the fact that the above studies 
were carried out in the developed countries, where the 
prevalence of tuberculosis is relatively low; in contrast to 
the present study, which was undertaken in India. 
Sex Incidence: In the present study, males outnumbered 
female patients (46 vs 4). Males in general are more 
prone to mechanical stresses due to their tall stature and 
strenuous work. Smoking is a more frequent habit, and 
tuberculosis and COPD are more frequent in males. 
Hence the disease seems to be more common in male 
gender and the results of these studies are all comparable 
to that of the present study.  
Symptoms: The study done by Kamat reported cough 
(94%) to be the most common symptom. This was 
followed by fever (76%), chest pain (75%) and dyspnea 
(53%). In the present study the commonest presentation 
of empyema thoracic was cough (92%), followed by fever 
(88%), SOB (84%) chest pain (60%), and weight loss 
(44%).The clinical manifestations of empyema can vary 
of widely depending on both the nature of the infecting 
organism and the system. The spectrum ranges from an 
almost complete absence of symptoms to a severe illness 
with systemic toxicity. In general, anaerobic and 
tubercular empyema usually present with a sub-acute 
illness, whereas aerobic bacterial infections present with 
an acute illness.[22-23] 
Laterality of Empyema: Empyema occurred more 
frequently on the right side 38(76%) than the left 
11(22%). Bilateral empyemas was seen in 1(2%) the 
present study. It is evident from the present study (76%) 
that the disease was more common on right side. In 
R.K.Tandon et al, it was 57.14%. This is probably due to 
the greater bulk of the right lung .Bilateral payothorax is 
quite an infrequent occurrence in all the series. In a study 
by Glena Cheng and Jamie RE Vintch, “A retrospective 
analysis of the management of para pneumonic 
empyemas in a country teaching facility from 1992 to 
2004”also alcohol abuse and tobacco abuse were among 
the common social co morbidities of the 72% empyema 
patients, which is comparable to the present study (82%).  
Etiology: In the present study, infectious etiology is more 
common because this study was carried out in a TB and 
chest diseases ward and patients of posttraumatic and 
postsurgical empyema were excluded from the study. The 
most common etiology was tuberculosis in 26(52%) 
patients, followed by community acquired pneumonia in 
19 (38%) and lung abscess in 3(6%). 
Microbiology: Prior to the availability of antibiotics, 
streptococcus pneumoniae and streptococcus pyogenes 
accounted for most empyemas. After the discovery and 
widespread use of penicillin in the 1940s, staphylococcus 
aureus succeeded S. pneumoniae and S.pyogenesas the 
major cause of empyema-lactamase.resistant. Since the 
semi synthetic penicillins in the early 1960s, the 
incidence of staphylococcal empyema has decreased, and 
infections due to anaerobic bacteria 
(Bacteroides,Peptostreptococci and Fusobacteria) and 
aerobic gram-negative bacilli (E. coli, Pseudomonas, 
Proteus, Klebsiella) have increased markedly. 
Approximately 75% of patients with empyema have 
multiple infecting organisms averaging three bacterial 
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species per patient. The pathogen isolated also depends 
on presence or Predisposing factors like community-
acquired pneumonia (S. pneumoniae), h/o aspiration 
(anaerobes), sub diaphragmatic infections (aerobic gram-
negative enteric bacilli), external trauma and hemothorax 
(Staphylococcus aureus) and immunosuppression 
(Staphyhlococcusaureus, Mycobacteria).In the present 
study many cases were sterile 30(60%). Bacteriological 
isolation was seen in 20 (40%) cases. Majority were 
12(24%) showing gram negative organisms. Among the 
gram negative Organisms, pseudomonas 8(16%) were the 
commonest organism isolated. Followed by E coli 2(4%), 
Klebsiella 1(2%) This is in concurrence with the reports 
of various workers who have emphasized the emergence 
of gram-negative bacilli as predominant. This negative 
culture report in present series was related with good 
number of tuberculouspyopneumothorax. Mycobacteria 
tuberculosis organisms do not grow on ordinary media. 
Special media like Twin 90 and Dorset egg media will 
take six weeks to grow. 
Radiology: If one goes through the investigations in a 
case of empyema thoracic, it is uncommon to find a big 
pile of X-rays, sometimes the number of x-rays equal the 
number of days of hospital stay. The amount of radiation 
exposure in these patients is a matter of concern. In the 
present study X-ray postero-anterior and lateral view was 
done at the time of admission, next X-ray was taken to 
know the tube position and the degree of lung expansion. 
Subsequently the patients were subjected to X-ray chest 
every 5 days to confirm the clinical findings, till the ICD 
was removed and finally before the discharge. Ultra 
sonography / CT was done in 42(84%) of the cases at the 
time of admission, 8(16%) had multiple loculations, 
24(56%) were non-loculated, 6(12%) had pyo-
pneumothorax with loculations. All HPTs at the time of 
diagnosis were tubercular cases. A study done by 
Kearney SE et al [24] (1999) reported 7/36 (19%) pleural 
collections were anechoic or non-loculated, 5/36 (14%) 
were hyperechoic without septae and 24/36 (67%) were 
hyperechoic with septae/ multiple loculi.The appearances 
of empyema on ultrasound probably represent different 
stages of the disease process. Anechoic or hypo-echoic, 
non-septated fluid precedes hyperechoic fluid and later on 
Septations or loculations develop. This may correlate with 
progression of empyema from the exudative to 
fibrinopurulent stage when increasing fibrin deposition 
causes formation of Septations and loculations in the 
pleural fluid and a rind or peel on the pleural surface. 
Septations, loculations and thickness of the pleural rind 
are easy to assess on ultrasound. 
Pleural Fluid Analysis: Grossly purulent fluid was seen 
in 45/50(87.5%) of the cases and 5/50(10%) had 
seropurulent effusion. 
Glucose &Protein: Tubercular empyema patients had 
glucose mean value 52.2 mg/dl, protein 3.4mg/dl while 
glucose mean was 40.4 mg/dl in non-tubercular cases; 
protein mean was 3.4gm/dl. 
Cell Count: TLC average was 1026.6, 1500.2 in 
tubercular and non-tubercular cases respectively. Both 
were PMN predominant. 
[25-29]
 
                  Table 15: Comparison of Tuberculosis & Non-Tuberculosis Cases of Empyema Thoracis 
 
Clinical Character S Kundu et al study Present Study 
 Tubercular Non-Tubercular Tubercular Non-Tubercular 
Age (mean) 32.7 46.5 yrs 30.6 yrs 48.5 yrs 
Duration of illness >1 
Month 
82.8% 28.3% 92% 29% 
Cough 82.8% 83.6% 84.6% 75% 
Fever 73.5% 100% 77 % 100% 
SOB 93.1% 100% 92.3% 100% 
Hemoptysis 24.3% 6.5% 30.7 % 4% 
BPF 48.8% 10.9% 64.5% 20.8% 
 
 
These results were comparable to those obtained in the 
present study. According to S Kundu et al and present 
study majority of tuberculous empyema cases belonged to 
a relatively younger age group (18–40 years), non-
tuberculous empyema patients were above 45 years of 
age. Majority cases of tuberculous empyema had it 
whereas only few cases (<29%) of non tuberculous 
empyema had duration of more than 1 month and mean 
duration of illness was significantly higher in tuberculous 
group compared to non tuberculous group.Hemoptysis & 
BPF was more common in tuberculous compared to non 
tuberculous empyema. 
 
Treatment &Outcome 
 
Despite being recognized since the ancient times, the 
appropriate management of empyema thoracis remains 
controversial. It may be postulated that the most 
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appropriate therapy depends on the stage of the disease at 
presentation.The literature provides  many  options 
including  antibiotics  alone  or  combination in with  
repeated thoracentesis, closed intercostal tube drainage, 
fibrinolytic agents like streptokinase or  
deoxyribonuclease, video-assisted  thoracoscopy, 
thoracotomy  and decortications.  However, the treatment 
objectives outlined by MAYO[29] are: 
• To save life 
• To eliminate the empyema, 
• To re-expand the trapped lung, 
• To restore mobility to the chest wall and 
diaphragm, 
• To return the respiratory function to normal, 
• To eliminate complications or chronicity, and 
• To reduce the duration of hospital stay  
In the present study, 42/50(84%) were managed 
with ICD and antibiotics. Amount ofpus drained was 
1500-4000ml. 90% of the pleural drain occurred on the 
first 3 days. Minimum duration for lung expansion was 
seven days and maximum of 45 days. The time taken for 
fever to subside ranged from 4-10 days.Seventeen 
patients (65.4%) in the tuberculous empyema group 
required ICTD for more than 1 month compared to only 
6(25%) in the non-tuberculous group; mean duration of 
intercostal tube drainage was also higher in the tubercular 
group (40.7 days) as against the non-tubercular group 
(20.2 days). BPF was seen in 17 (65.3) cases of 
tubercular, 5 (20.8%)of non-tubercular empyema.There is 
no practice of using intrapleuralfibrinolytic in our hospital 
setting and the other reason being cost constraints. Good 
lung expansion with minimal pleuralthickening seen in 23 
cases (95.8%) of non-tubercular cases. But only 14 
(53.3%) cases of tubercular empyema had resolution. 
Twelve patients (46.6%) with tuberculous empyema 
required surgery despite ATDs and ICTD, whereas only 
one (4%) in thenon-tuberculous group needed surgery. 
Follow-up:All patients were followed up after the 
discharge at 1 and 3 months. All of them were evaluated 
clinically and radiographically. Most of the patients 74% 
were asymptomatic and had good lung expansion. 8% 
were clinically normal but revealed pleural thickening.8 
% had persistent collapse. 
 
Conclusion 
 
Empyema continues to be prevalent in our country 
particularly in the lower socioeconomic strata due to the 
delay in seeking medical care, inappropriate antibiotics 
and dosages and duration of antibiotic treatment.  
➢ Empyema fluid is diagnostic for pathogens if 
appropriate handling and early cultures but in 
the present scenario with prior antibiotic 
treatment, the fluid is sterile most of the times. 
Pleural fluid biochemical parameters would also 
vary depending on the stage of empyema, 
severity and previous antibiotic therapy.  
➢ Tuberculous empyema remains a common cause 
of empyema thoracis in our country India. 
Tuberculous empyema differs from non-
tuberculous empyema in the age profile, Clinical 
presentation, management issues, and has a 
significantly poorer outcome.  
➢ Ultrasonography is non-invasive, gives no 
radiation, is easily available and is an ideal 
investigation for staging, detecting loculations 
and planning the treatment. CT thorax is 
preferred in complicated empyemas.  
➢ Management of primary empyema continues to 
be controversial in terms of duration of 
antibiotic therapy and the indications for and 
timing of surgery. There is a need for 
randomized controlled trials for strict guidelines 
on the management of empyema. 
Summary 
• This was a prospective study of empyema 
thorasis in adults done in Govt. TB&Chest 
Hospital Hanamkonda. 50 cases of were 
evaluated for the clinical course of the disease 
and bacteriological profile. 
• Most  affected  patients  were  in  the  age group  
of 3 1 -50  years  (66%), Males outnumbered 
females, with a male to female ratio of 11.  
• The most common etiology was tuberculosis in 
26(52%) patients, followed by community 
acquired pneumonia in 19 (38%) and lung 
abscess in 3(6%).  
• Many cases were sterile 30(60%). 
Bacteriological isolation was seen in 20 (40%) 
cases.  
• Majority were 12(24%) showing gram negative 
organisms. Among the gram negative 
Organisms, pseudomonas 8(16%) were the 
commonest organism isolated. Followed by E 
coli 2(4%), Klebsiella 1(2%).Among the gram 
positive organisms, staphylococci 4 (8%) and 
pneumococci 1(2%) were the commonest 
organisms isolated .one case was showing 
polymicrobial variety. 
• Pus for AFB stain was seen in 3 cases, all were 
sputum positive. 
• 38  (76%)  had  pleural effusion  on  X-ray  and  
12(24%)  cases  had Hydropneumothorax.  All 
HPTs at the time of diagnosis were tubercular 
cases. 
• 8(16%) of the cases had loculated empyema as 
most of them were in chronic presentation group 
(fibrinopurulent stage), 28 (56%) had non-
loculated and 6 (12%) had pyopneumothorax 
with loculations. 
• The majority (21 cases, 80.7%) of tuberculous 
empyema cases belonged to a relatively younger 
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age group (18–40 years), whereas 66.7% (16 
cases) of non tuberculous empyema patients 
were above 45 years of age. 
• Mean duration of illness was significantly 
higher in tuberculous group (mean 78.6 days) 
compared to non tuberculous group (mean 21.4 
days). 
• Many tubercular patients 14(53.8%) were had 
BMI<18.5, only 5 cases (20.8%) of non-
tubercular patients were belonged to this group. 
past h/o PTB was significant in tubercular cases 
73% (19 cases) many were defaulters.  
• Tubercular empyema patients had pleural fluid 
glucose mean value 52.2 mg/dl, protein 
3.4mg/dl while glucose mean was 40.4 mg/dl in 
non-tubercular cases, protein mean was 
3.4gm/dl;both empyema cases were PMN 
predominant.ADA mean was 58.6, LDH 
mean1536.7 in tubercular 276, 6030.2 
respectively in non-tubercular. 
• Mean duration of intercostal tube drainage was 
also higher in the tubercular group (40.7 days) 
as against the non-tubercular group (20.2 days). 
BPF was seen in 17 (65.3) cases of tubercular, 5 
(20.8%) of non-tubercular empyema. 
• Good lung expansion with minimal pleural 
thickening seen in 23 cases (95.8%) of non-
tubercular cases. But only 14 (53.3%) cases of 
tubercular empyema had resolution. All 6 (12%) 
loculated HPTs were tubercular and showed 
persistent BPF required surgery twelve patients 
(46.6%) with tuberculous empyema required 
surgery despite ATT and ICTD, whereas only 
one (4%) in the non-tuberculous group needed 
surgery. 
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